Serum polysialylated neural cell adhesion molecule in childhood neuroblastoma.

[1]  D. Figarella-Branger,et al.  Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. R. Smith,et al.  Serum neural cell adhesion molecule in multiple myeloma and other plasma cell disorders , 1996, British journal of haematology.

[3]  F. Lottspeich,et al.  Molecular cloning and functional expression of bacteriophage PK1E‐encoded endoneuraminidase Endo NE , 1995, Molecular microbiology.

[4]  G. Jaques,et al.  Characterization of tumor-associated neural cell adhesion molecule in human serum. , 1994, Cancer research.

[5]  G. Rougon Structure, metabolism and cell biology of polysialic acids. , 1993, European journal of cell biology.

[6]  U. Rutishauser,et al.  Intercellular space is affected by the polysialic acid content of NCAM , 1992, The Journal of cell biology.

[7]  P. Lacor,et al.  Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells , 1991, British journal of haematology.

[8]  D. Bitter‐Suermann,et al.  Embryonic Neural Cell Adhesion Molecule in Cerebrospinal Fluid of Younger Children: Age‐Dependent Decrease During the First Year , 1990, Journal of neurochemistry.

[9]  C. Figdor,et al.  Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. , 1990, Cancer research.

[10]  F. Walsh,et al.  Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM) , 1989, International journal of cancer.

[11]  D. Bitter‐Suermann,et al.  Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding. , 1989, Molecular immunology.

[12]  K. Timmis,et al.  NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  H. B. Marsden,et al.  Histologic patterns of neuroblastoma related to prognosis and clinical staging , 1974, Cancer.

[15]  G. Jaques,et al.  Serum NCAM: a potential new prognostic marker for multiple myeloma. , 1994, Blood.

[16]  G. Pelosi,et al.  Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small‐cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone‐marrow infiltration , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[17]  T. Grogan,et al.  Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). , 1990, Blood.